Belimumab

Category: Immune System



Belimumab Overview

Belimumab (trade name Benlysta, previously known as LymphoStat-B) is a human monoclonal antibody that inhibits B-cell activating factor (BAFF),[1] also known as B-lymphocyte stimulator (BLyS).[2] It is approved in the United States, Canada, and Europe to treat systemic lupus erythematosus (SLE). Contents 1 Uses 2 Side effects and interactions 3 Mechanism of action 4 Discovery and history 5 FDA approval 6 Cost 7 Related drugs 8 References Uses Belimumab...

Read more Belimumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Belimumab

Recent Belimumab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Belimumab
  • Injection: 120mg, 200mg/ml, 400mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Belimumab or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 21 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA